Results 71 to 80 of about 267,960 (152)
A dermatopathic juvenile dermatomyositis; an unexpected case in childhood [PDF]
Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory disease which usually presents with skin rashes along with muscle weakness. We report a case of JDM in a 10- year-old girl with no skin manifestations.She was presented with progressive ...
Ahmadi, P. +13 more
core +1 more source
Intramural ureteric calcification in dermatomyositis mimicking pelviureteric junction obstruction
Juvenile dermatomyositis classically manifests as necrotising vasculitis in multiple organs. It mainly involves the vessels of skin and muscle and is associated with subcutaneous deposits of calcium.
Shah Amar, Thakur Rakesh, Parashar Karan
doaj
Sera from patients with anti‐MDA5‐positive dermatomyositis‐associated interstitial lung disease (ILD) exhibit significantly higher type I interferon (IFN‐I) bioactivity and interferon‐stimulated gene‐inducing activity compared to anti‐ARS‐positive ILD and healthy controls.
Shohei Nakamura +3 more
wiley +1 more source
Cardiac findings in children with juvenile Dermatomyositis at disease presentation
Background: Juvenile Dermatomyositis (JDM) is a pediatric vasculopathy characterized primarily by skin and muscle involvement.
Gross, Gil J. +3 more
core +1 more source
Dermatomyositis Associated with Celiac Disease: Response to a Gluten-Free Diet
The association between dermatomyositis and celiac disease in children has been well documented. In the adult population, however, the association has not been clearly established.
Min Soo Song +5 more
doaj +1 more source
Children with prenatal alcohol exposure (PAE) exhibit early alterations in their microvasculature. Using nailfold capillaroscopy, a noninvasive imaging technique, we compared nailfold capillary morphology in 27 children with PAE and 10 unexposed peers (3–17 years).
Florencia Anunziata +8 more
wiley +1 more source
Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling [PDF]
OBJECTIVE: In patients with severe or refractory juvenile dermatomyositis (JDM), second-line treatments may be required. Cyclophosphamide (CYC) is used to treat some connective tissue diseases, but evidence of efficacy in JDM is limited. This study aimed
Simou, S +7 more
core +1 more source
Cricoarytenoid joint arthritis: a possible complication of dermatomyositis
Cricoarytenoid joint arthritis is most frequently reported in Rheumatoid Arthritis and in other systemic diseases such as Sjogren´s syndrome, Systemic Lupus Erythematosus, Ankylosing Arthritis, Juvenile Chronic Arthritis, and autoimmune hepatitis but it ...
Chadi Farah +4 more
doaj +1 more source
Objective Calcinosis cutis (CC) is dystrophic calcification affecting 20% to 40% of patients with juvenile dermatomyositis (JDM). Management of CC is often challenging owing to its being refractory to usual therapeutic options. Type I interferon (IFN)‐mediated immune dysregulation may be involved in the pathogenic role in CC, suggesting that altering ...
Pragati Jain +11 more
wiley +1 more source
Juvenile dermatomyositis (JDM) is a chronic multisystem inflammatory disease that primarily involves skin and muscles. The clinical picture is mainly characterized by the typical cutaneous rash and by skeletal muscle weakness. Nevertheless the vasculitic process may extend in some cases to other organs such as lung, joints or gastrointestinal system ...
MARTINI, ALBERTO +3 more
openaire +2 more sources

